Home / Stocks / STVN

Stevanato Group S.p.A. (STVN, Life Sciences Tools & Services) Stock Valuation & Fair Value Trading above fair value

Stevanato Group S.p.A. (STVN, Life Sciences Tools & Services) trades at a blended P/E of 31.9, about 16% below its historical normal valuation, with a forward growth estimate of 19.5% and a PEG of 1.63. Analysts' one-year estimates have been hit 50% of the time. Priced at its historical normal P/E of 38.2 on the same blended earnings, the 2026-09-18 close of $21.70 corresponds to about $26.00 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-09-21
Blended P/E
31.9
Normal P/E
38.2
PEG
1.63
Fwd growth
19.5%
Div yield
0.3%
RSI (14)
54.6
Neutral
Technical context
  • Price $21.69 at the 2026-09-23 close, 1.4% above the 20-day average ($21.39) and 4.2% above the 50-day ($20.81).
  • RSI (14) at 54.6.
  • 52-week range $13.38 to $27.51: the price is 21.2% below the high and 62.1% above the low.

The Street vs SeerForecast

Wall Street's mean price target for STVN is $24.68 across 12 analysts, 13.8% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: trading above fair value. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been trading above fair value since 2026-07-31.

Blended P/E and rating by weekBlended P/E moved from 30.6 to 31.9 between 2026-07-31 and 2026-09-21, against a normal P/E of 38.2, with 0 rating changes over 18 recorded weeks.2026-07-31: P/E 30.6, Trading above fair value (recalculated)2026-08-03: P/E 30.0, Trading above fair value2026-08-07: P/E 30.0, Trading above fair value (recalculated)2026-08-10: P/E 30.3, Trading above fair value2026-08-14: P/E 30.3, Trading above fair value (recalculated)2026-08-17: P/E 31.4, Trading above fair value2026-08-21: P/E 31.4, Trading above fair value (recalculated)2026-08-24: P/E 33.6, Trading above fair value2026-08-27: P/E 33.6, Trading above fair value (recalculated)2026-08-28: P/E 33.6, Trading above fair value (recalculated)2026-08-30: P/E 33.6, Trading above fair value (recalculated)2026-08-31: P/E 31.1, Trading above fair value2026-09-05: P/E 31.1, Trading above fair value (recalculated)2026-09-07: P/E 30.3, Trading above fair value2026-09-12: P/E 30.3, Trading above fair value (recalculated)2026-09-14: P/E 30.8, Trading above fair value2026-09-19: P/E 30.8, Trading above fair value (recalculated)2026-09-21: P/E 31.9, Trading above fair value32.535.037.5Jul 31Aug 13Aug 26Sep 8Sep 21Normal P/E 38.2
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-07-31P/E 30.6-20%Trading above fair value
2026-08-03P/E 30.0-21%Trading above fair value
2026-08-24P/E 33.6-12%Trading above fair value
2026-09-21P/E 31.9-16%Trading above fair value ← now

Frequently asked questions

Is Stevanato Group S.p.A. stock overvalued?

At a blended P/E of 31.9 versus its historical normal P/E of 38.2, Stevanato Group S.p.A. trades about 16% below its typical valuation, with a PEG of 1.63 on 19.5% forward growth. tickerseer currently rates it trading above fair value.

What is Stevanato Group S.p.A.'s fair value and PEG?

Stevanato Group S.p.A. trades at a blended P/E of 31.9 against a historical normal P/E of 38.2, a PEG of 1.63, and a forward growth estimate of 19.5%. Priced at its historical normal P/E of 38.2 on the same blended earnings, the 2026-09-18 close of $21.70 corresponds to about $26.00 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Stevanato Group S.p.A. changed?

tickerseer's rating has been trading above fair value since 2026-07-31.

What is the analyst price target for Stevanato Group S.p.A.?

The mean Wall Street price target for Stevanato Group S.p.A. is $24.68 across 12 analysts, 13.8% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track STVN free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.